As part of our ongoing review of our editorial structure, the Topical Advisor Panel (TAP) role will be discontinued effective January 1, 2027.
Topical Advisory Panel for section 'Radiopharmaceutical Sciences'
- Medicinal Chemistry Section
- Biopharmaceuticals Section
- Natural Products Section
- Radiopharmaceutical Sciences Section
- Pharmacology Section
- Pharmaceutical Technology Section
Please see the section webpage for more information on this section.
Members
South Australian Health and Medical Research Institute, Adelaide, SA, Australia
Interests: pet imaging; medicinal chemistry; CNS drug discovery
Interests: pet imaging; medicinal chemistry; CNS drug discovery
Department of Nuclear Medicine, Universitätsmedizin Göttingen, Gottingen, Germany
Interests: PET; SPECT
Interests: PET; SPECT
Medizinische Universitat Wien, Vienna, Austria
Interests: experimental nuclear medicine; preclinical imaging; tracer development
Interests: experimental nuclear medicine; preclinical imaging; tracer development
Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095, USA
Interests: metabolism and cancer; nuclear medicine; radiochemistry
Special Issues, Collections and Topics in MDPI journals
Interests: metabolism and cancer; nuclear medicine; radiochemistry
Special Issues, Collections and Topics in MDPI journals
Department of Radiology, New York-Presbyterian Hospital, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA
Interests: nuclear medicine; radiology; oncology; radiomics; AI
Special Issues, Collections and Topics in MDPI journals
Interests: nuclear medicine; radiology; oncology; radiomics; AI
Special Issues, Collections and Topics in MDPI journals
